Cirrhosis, Hepatecellular Carcinoma, Hepatectomy
Conditions
Brief summary
Selection criteria for safe hepatectomy for HCC are not well established. The aim of this study was the validation of the selection criteria for safe hepatectomy for hepatocellular carcinoma.
Detailed description
All consecutive patients submitted to hepatectomy for HCC based on the same preoperative selection criteria from our prospectively-maintained liver unit database. Such criteria included the value of bilirubin (BIL), the value of cholinesterases (CHE), the presence of ascites, the presence of esophageal varices, and the rate of residual liver volume.
Interventions
PROCEDUREHepatectomy
Sponsors
University of Milan
Study design
Observational model
COHORT
Time perspective
RETROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No
Inclusion criteria
* any patient with HCC submitted to hepatic resection at our Unit in the established frame time
Exclusion criteria
* any patient with missing data or lost at follow-up
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Safety of surgery for HCC | 90 days | The primary endpoint was the validation of our selection criteria for safe hepatectomy for HCC in regards to postoperative complications. The role of total bilirubin and cholinesterases was analzyed together with other clinical parameters. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Score systems HCC | 90 days | The secondary endpoint was the testing of the most common score systems for HCC, which are the CPT score, the MELD score, and the APRI score. |
Countries
Italy
Outcome results
None listed